Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 113001-113050 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT02740634
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
NA
Recruiting
60 participants
Started: May 31, 2016 · Completed: Mar 31, 2026
8 conditions
2 sponsors
1 location
NCT02811224
Ovarian Cancer Hemoscope Trial
N/A
Active, not recruiting
50 participants
Started: May 31, 2016 · Completed: Jul 31, 2030
1 condition
1 sponsor
0 locations
NCT02785848
Identifying Barriers and Strategies to Support Self-efficacy for Medication Adherence With Text Messaging
N/A
Active, not recruiting
70 participants
Started: May 31, 2016 · Completed: Jul 31, 2028
1 condition
1 sponsor
1 location
NCT02852031
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
N/A
Recruiting
1,000 participants
Started: May 31, 2016 · Completed: May 31, 2028
1 condition
1 sponsor
63 locations
NCT03030755
Corneal Elastography and Patient Specific Modeling
N/A
Recruiting
60 participants
Started: May 31, 2016 · Completed: May 31, 2026
3 conditions
1 sponsor
1 location
NCT02938702
Active Surveillance on Papillary Thyroid Microcarcinoma
N/A
Active, not recruiting
1,211 participants
Started: May 31, 2016 · Completed: Mar 31, 2030
2 conditions
1 sponsor
1 location
NCT03150576
Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer
PHASE2/PHASE3
Recruiting
780 participants
Started: May 31, 2016 · Completed: Jun 30, 2034
1 condition
3 sponsors
30 locations
NCT02788461
Assessing the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy
NA
Active, not recruiting
78 participants
Started: May 31, 2016 · Completed: Apr 30, 2026
1 condition
1 sponsor
7 locations
NCT02781883
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
PHASE2
Recruiting
108 participants
Started: May 31, 2016 · Completed: Dec 31, 2028
1 condition
1 sponsor
9 locations
NCT02772588
AASUR in High Risk Prostate Cancer
PHASE2
Active, not recruiting
64 participants
Started: May 31, 2016 · Completed: May 31, 2026
1 condition
4 sponsors
11 locations
NCT03514784
Combination Probiotic: BB-12 With LGG (Different Doses) in Treating Children With Autism Spectrum Disorder
PHASE1/PHASE2
Recruiting
70 participants
Started: May 31, 2016 · Completed: Dec 31, 2025
2 conditions
3 sponsors
1 location
NCT03014401
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
NA
Recruiting
29 participants
Started: May 31, 2016 · Completed: Dec 31, 2025
1 condition
2 sponsors
3 locations
NCT06066268
miRNAs in Critical Limb Ischemia (miRNACLI)
N/A
Recruiting
80 participants
Started: May 31, 2016 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT02781857
Mass Spectral Fingerprinting in Lung Cancer
N/A
Active, not recruiting
393 participants
Started: May 31, 2016 · Completed: Mar 31, 2025
1 condition
2 sponsors
1 location
NCT02861794
Stability of Contemporary Knee Arthroplasty
NA
Active, not recruiting
31 participants
Started: May 31, 2016 · Completed: Dec 31, 2024
1 condition
3 sponsors
1 location
NCT02787369
ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL
PHASE1
Active, not recruiting
3 participants
Started: May 31, 2016 · Completed: Apr 30, 2027
1 condition
2 sponsors
1 location
NCT02967822
Molecular Genetic Study of Mayer-Rokitansky-Kuster-Hauser Syndrome
N/A
Recruiting
410 participants
Started: May 31, 2016 · Completed: May 31, 2031
1 condition
2 sponsors
2 locations
NCT02791685
Smartphone Delivered In-home Cardiopulmonary Rehabilitation
NA
Active, not recruiting
300 participants
Started: May 31, 2016 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT02910323
The Will Erwin Headache Research Center - Cluster Headache Study
N/A
Recruiting
1,500 participants
Started: May 31, 2016 · Completed: Dec 31, 2035
6 conditions
1 sponsor
1 location
NCT03902444
AcandiS Stenting of Intracranial STENosis - regisTry
N/A
Recruiting
150 participants
Started: May 31, 2016 · Completed: Oct 31, 2025
1 condition
1 sponsor
16 locations
NCT02704455
Registry Study on Primary Ciliary Dyskinesia in Chinese Children
N/A
Not yet recruiting
100 participants
Started: May 31, 2016 · Completed: Jul 31, 2030
1 condition
7 sponsors
0 locations
NCT03319758
Esthetic and Radiographic Outcomes Following Immediate Implant Placement With Thin or Dehiscence Buccal Bone Wall
NA
Active, not recruiting
15 participants
Started: May 31, 2016 · Completed: Nov 30, 2027
2 conditions
1 sponsor
1 location
NCT07194811
Stroke of Unknown Cause in Women: The Impact of Long-term Heart Monitoring on Stroke Recurrence
N/A
Active, not recruiting
1,400 participants
Started: May 31, 2016 · Completed: Dec 31, 2025
7 conditions
5 sponsors
1 location
NCT02755272
A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
PHASE2
Active, not recruiting
87 participants
Started: May 31, 2016 · Completed: May 31, 2026
1 condition
2 sponsors
6 locations
NCT02775227
HYPAR Trial - Hydrocortisone vs. Pasireotide in Reducing Pancreatic Surgery Complications
PHASE4
Active, not recruiting
126 participants
Started: May 31, 2016 · Completed: Dec 31, 2029
2 conditions
1 sponsor
1 location
NCT02243033
Phase II Laser Focal Therapy of Prostate Cancer
N/A
Active, not recruiting
1,000 participants
Started: May 31, 2016 · Completed: Nov 30, 2036
1 condition
1 sponsor
1 location
NCT02768363
Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
PHASE2
Active, not recruiting
187 participants
Started: May 31, 2016 · Completed: Dec 31, 2026
1 condition
1 sponsor
23 locations
NCT02800486
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
PHASE2
Recruiting
37 participants
Started: May 31, 2016 · Completed: May 31, 2027
9 conditions
1 sponsor
1 location
NCT02807766
Brain Plasticity of Autism in Response to Early Behavioral Intervention: A Multimodal MRI Study
NA
Recruiting
150 participants
Started: May 31, 2016 · Completed: Dec 31, 2024
1 condition
1 sponsor
2 locations
NCT02758652
Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer
N/A
Active, not recruiting
160 participants
Started: May 31, 2016 · Completed: May 31, 2026
1 condition
3 sponsors
1 location
NCT02812290
Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation
N/A
Recruiting
700 participants
Started: May 31, 2016 · Completed: Jun 30, 2026
1 condition
1 sponsor
11 locations
NCT02965326
Surrogate Markers of Response to New Therapies in Cystic Fibrosis Patients
NA
Recruiting
75 participants
Started: May 31, 2016 · Completed: Oct 31, 2026
1 condition
3 sponsors
1 location
NCT03053141
RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
N/A
Recruiting
100 participants
Started: May 31, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
7 locations
NCT03268135
Heart Failure and Aortic Stenosis Transcriptome
N/A
Recruiting
500 participants
Started: May 30, 2016 · Completed: Dec 31, 2027
2 conditions
2 sponsors
2 locations
NCT06360575
Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Exon 14 Deletion Genetic Changes (MATCH - Subprotocol C2)
PHASE2
Active, not recruiting
35 participants
Started: May 30, 2016 · Completed: Nov 15, 2025
5 conditions
1 sponsor
1 location
NCT06357975
Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Genetic Changes (MATCH - Subprotocol C1)
PHASE2
Active, not recruiting
50 participants
Started: May 30, 2016 · Completed: Nov 15, 2025
5 conditions
1 sponsor
1 location
NCT04635046
Effects on Patient Satisfaction and Gait After Loss of Peroneus Longus Function
N/A
Active, not recruiting
50 participants
Started: May 30, 2016 · Completed: May 31, 2024
2 conditions
1 sponsor
1 location
NCT02992574
Trial Evaluating Role of Post Mastectomy Radiotherapy in Women With Node Negative Early Breast Cancer
NA
Recruiting
1,022 participants
Started: May 27, 2016 · Completed: Dec 31, 2033
1 condition
1 sponsor
7 locations
NCT03454763
Optimizing the Interval Between Cycles of PRRT with 177lu-dotatate in Sstr2 Positive Tumors
PHASE2
Active, not recruiting
618 participants
Started: May 26, 2016 · Completed: Jan 31, 2025
1 condition
1 sponsor
1 location
NCT02710253
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
PHASE2
Recruiting
230 participants
Started: May 25, 2016 · Completed: May 30, 2026
2 conditions
2 sponsors
5 locations
NCT02738606
Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery
PHASE2
Active, not recruiting
29 participants
Started: May 25, 2016 · Completed: Dec 31, 2025
8 conditions
2 sponsors
1 location
NCT02795806
NLM Scrubber: NLM s Software Application to De-identify Clinical Text Documents
N/A
Enrolling by invitation
50,000 participants
Started: May 25, 2016 · Completed: Jan 31, 2027
1 condition
3 sponsors
1 location
NCT02790853
Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders
EARLY_PHASE1
Active, not recruiting
63 participants
Started: May 25, 2016 · Completed: May 31, 2026
4 conditions
2 sponsors
1 location
NCT02735252
PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer
NA
Active, not recruiting
156 participants
Started: May 25, 2016 · Completed: Mar 31, 2027
4 conditions
3 sponsors
1 location
NCT02764541
Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)
PHASE2
Active, not recruiting
195 participants
Started: May 24, 2016 · Completed: Apr 30, 2031
1 condition
2 sponsors
11 locations
NCT02609776
Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer
PHASE1
Active, not recruiting
751 participants
Started: May 24, 2016 · Completed: Dec 31, 2026
1 condition
1 sponsor
69 locations
NCT03778112
MRI Guided SBRT for Localized Prostate Cancer
NA
Active, not recruiting
54 participants
Started: May 23, 2016 · Completed: Mar 31, 2029
1 condition
1 sponsor
1 location
NCT02345265
Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer
PHASE2
Active, not recruiting
70 participants
Started: May 23, 2016 · Completed: Aug 8, 2026
9 conditions
1 sponsor
20 locations
NCT02684292
Study of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-204/KEYNOTE-204)
PHASE3
Active, not recruiting
304 participants
Started: May 23, 2016 · Completed: Jan 12, 2026
1 condition
1 sponsor
0 locations
NCT03703778
Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study)
N/A
Active, not recruiting
300 participants
Started: May 22, 2016 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
Previous
1
More pages
2258
2259
2260
2261
2262
2263
2264
More pages
2369
Next